Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Prognosis of adults with idiopathic pulmonary fibrosis without treatment or without effective therapies

Information

DOI:
https://doi.org/10.1002/14651858.CD012647Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 26 April 2017see what's new
Type:
  1. Prognosis
Stage:
  1. Protocol
Cochrane Editorial Group:
  1. Cochrane Airways Group

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Yet H Khor

    Correspondence to: Department of Respiratory and Sleep Medicine, Austin Health, Melbourne, Australia

    [email protected]

    [email protected]

    Institute for Breathing and Sleep, Austin Health, Melbourne, Australia

    Department of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne, Australia

    Department of Medicine, University of Melbourne, Melbourne, Australia

  • Yvonne Ng

    Institute for Breathing and Sleep, Austin Health, Melbourne, Australia

  • Nicole SL Goh

    Department of Respiratory and Sleep Medicine, Austin Health, Melbourne, Australia

    Institute for Breathing and Sleep, Austin Health, Melbourne, Australia

    Department of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne, Australia

  • Christine F McDonald

    Department of Respiratory and Sleep Medicine, Austin Health, Melbourne, Australia

    Institute for Breathing and Sleep, Austin Health, Melbourne, Australia

    Department of Medicine, University of Melbourne, Melbourne, Australia

  • Anne E Holland

    Institute for Breathing and Sleep, Austin Health, Melbourne, Australia

    Discipline of Physiotherapy, School of Allied Health, Department of Rehabilitation, Nutrition and Sport, La Trobe University, Melbourne, Australia

    Department of Physiotherapy, The Alfred Hospital, Melbourne, Australia

Contributions of authors

Coordinating the review: YHK
Drafting protocol and review: YHK, NG, CM, AH
Designing search strategies: YHK, Cochrane Airways Group Information Specialist (Elizabeth Stovold)
Data collection for the review: YHK, YN
Data analysis: YHK, AH
Data interpretation: YHK, NG, CM, AH

Sources of support

Internal sources

  • Department of Respiratory and Sleep Medicine, Austin Health, Australia.

    Support to YHK, NG and CM

  • Institute for Breathing and Sleep, Australia.

    Support to YHK, YN, NG, CM and AH

  • School of Allied Health, La Trobe University, Australia.

    Support to AH

External sources

  • National Health and Medical Research Council, Australia.

    YHK is supported by the National Health and Medical Research Council Postgraduate Scholarship.

Declarations of interest

YHK: None known
YN: None known
NG: None known
AH: None known
CM has received personal fees for participation in advisory boards for Pfizer and Novartis; has participated in advisory board for Astra Zeneca (no fee); has received speakers fees from GSK and Novartis; and has received in‐kind support for a research project from Air Liquide.

Acknowledgements

Haydn Walters and Katriana Williams were the Editors for this review and commented critically on the review.

This work was supported by the Cochrane Prognosis Methods Group for the development of the study protocol.

This project was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding to the Cochrane Airways Group. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, National Health Service (NHS), or the Department of Health.

Version history

Published

Title

Stage

Authors

Version

2017 Apr 26

Prognosis of adults with idiopathic pulmonary fibrosis without treatment or without effective therapies

Protocol

Yet H Khor, Yvonne Ng, Nicole SL Goh, Christine F McDonald, Anne E Holland

https://doi.org/10.1002/14651858.CD012647

Table 1. Assessing the risk of bias

Criteria

High risk of bias

Low risk of bias

Unclear/other

Sample

Clinical

Population

Unclear

Recruitment

Retrospective

Prospective

Unclear

Selection criteria for participants

No

Yes

Unclear

Baseline characteristics of participants

No

Yes

Unclear

Follow‐up percentage

(if RCT)

< 80%

≥ 80%

Unclear

Not applicable

Follow‐up duration

< 1 year

≥ 1 year

Unclear

Reason lost to follow‐up

No

Yes

Unclear

Timing of diagnosis

At the conclusion of the study

At baseline or before recruitment to study

Unclear

Blinding

Not blinded

Blinding adequate

Unclear

Outcome described a priori

No

Yes

Unclear

Intention‐to‐treat analysis (if RCT)

No

Yes

Unclear

Not applicable

Adequate description of statistical analysis

No

Yes

Unclear

Figures and Tables -
Table 1. Assessing the risk of bias